Improving control of infectious laryngotracheitis in Australian broiler flocks

The University of Melbourne

  • Project code: PRJ-005743

  • Project stage: Closed

  • Project start date: Sunday, August 1, 2010

  • Project completion date: Monday, November 22, 2010

  • National Priority: CME-Priority 3-Contributing to efficient and secure chicken production systems


This travel relates to RIRDC project PRJ-003384 “Improving control of infectious laryngotracheitis (ILT) in Australian broiler flocks.” This project commenced in 2009.
A key focus of PRJ-003384 is to determine the relationship between field and vaccine isolates of ILTV and to develop improved diagnostic tools for detection and classification of these viruses. Similar to the situation in Australia, broiler producers in the USA are experiencing significant problems due to ILT. In the USA many of the virulent field strains of ILTV have recently been shown to be related to vaccine strains. Research performed within the laboratories of the hosting organization (The UGA Poultry Diagnostic Research Centre) has focussed on this research area. Attending this conference will provide an opportunity to learn about the techniques and findings from this work performed in the USA. This will then be used to develop and improve our own research in this area in order to ensure that PRJ-003384 progresses optimally. Other opportunities to learn and share valuable research techniques and information are also expected.


Chicken Meat

Research Organisation

The University of Melbourne

Objective Summary

This travel will allow Dr Sang-Won Lee to attend the 1st Symposium on Avian Herpesviruses. This first international conference on avian herpesviruses reflects the growing significance of these viruses, particularly ILTV, in poultry industries worldwide. As a postdoctoral research scientist employed on RIRDC project PRJ-003384, this travel would provide an opportunity for Dr Lee to present recent research in this project in a paper entitled “Whole genome sequencing of field and vaccine strains of infectious laryngotracheitis virus.”